Study of Carfilzomib and Vorinostat for Relapsed or Refractory Lymphoma
Clinical trial NCT01276717 · COMPLETED
Trial details
- NCT number
- NCT01276717
- Sponsor
- University of Rochester
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2013-07-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.